Citryll

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

SciRhom

This biopharmaceutical company develops monoclonal antibodies targeting iRhom2 to treat patients with autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.

Avalo Therapeutics

This clinical-stage biotechnology company develops monoclonal antibody therapies for patients with immune-mediated inflammatory diseases such as hidradenitis suppurativa.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

ILAb

This company develops small-molecule immune response modulating drugs for the treatment of rheumatoid arthritis and related autoimmune diseases for patients.